PLCG2 and colorectal carcinoma: In the study, we conducted a comprehensive analysis to reveal the role of PLCG2 as an important pro-oncogene in promoting CRC progression, forming an immunosuppressive microenvironment, and predicting immunotherapy sensitivity.